Gotowa bibliografia na temat „Lung epithelial barrier function”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Lung epithelial barrier function”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Lung epithelial barrier function"
Brune, Kieran, James Frank, Andreas Schwingshackl, James Finigan i Venkataramana K. Sidhaye. "Pulmonary epithelial barrier function: some new players and mechanisms". American Journal of Physiology-Lung Cellular and Molecular Physiology 308, nr 8 (15.04.2015): L731—L745. http://dx.doi.org/10.1152/ajplung.00309.2014.
Pełny tekst źródłaAghapour, Mahyar, Alexander H. V. Remels, Simon D. Pouwels, Dunja Bruder, Pieter S. Hiemstra, Suzanne M. Cloonan i Irene H. Heijink. "Mitochondria: at the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease". American Journal of Physiology-Lung Cellular and Molecular Physiology 318, nr 1 (1.01.2020): L149—L164. http://dx.doi.org/10.1152/ajplung.00329.2019.
Pełny tekst źródłaHollenhorst, Monika I., Katrin Richter i Martin Fronius. "Ion Transport by Pulmonary Epithelia". Journal of Biomedicine and Biotechnology 2011 (2011): 1–16. http://dx.doi.org/10.1155/2011/174306.
Pełny tekst źródłaHerrero, Raquel, Mishie Tanino, Lincoln S. Smith, Osamu Kajikawa, Venus A. Wong, Steve Mongovin, Gustavo Matute-Bello i Thomas R. Martin. "The Fas/FasL pathway impairs the alveolar fluid clearance in mouse lungs". American Journal of Physiology-Lung Cellular and Molecular Physiology 305, nr 5 (1.09.2013): L377—L388. http://dx.doi.org/10.1152/ajplung.00271.2012.
Pełny tekst źródłaKim, Kwang-Jin, i Asrar B. Malik. "Protein transport across the lung epithelial barrier". American Journal of Physiology-Lung Cellular and Molecular Physiology 284, nr 2 (1.02.2003): L247—L259. http://dx.doi.org/10.1152/ajplung.00235.2002.
Pełny tekst źródłaBao, Shenying, i Daren L. Knoell. "Zinc modulates cytokine-induced lung epithelial cell barrier permeability". American Journal of Physiology-Lung Cellular and Molecular Physiology 291, nr 6 (grudzień 2006): L1132—L1141. http://dx.doi.org/10.1152/ajplung.00207.2006.
Pełny tekst źródłaWu, Huijuan, i Nan Tang. "Stem cells in pulmonary alveolar regeneration". Development 148, nr 2 (15.01.2021): dev193458. http://dx.doi.org/10.1242/dev.193458.
Pełny tekst źródłaOvergaard, Christian E., Barbara Schlingmann, StevenClaude Dorsainvil White, Christina Ward, Xian Fan, Snehasikta Swarnakar, Lou Ann S. Brown, David M. Guidot i Michael Koval. "The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function". American Journal of Physiology-Lung Cellular and Molecular Physiology 308, nr 12 (15.06.2015): L1212—L1223. http://dx.doi.org/10.1152/ajplung.00042.2014.
Pełny tekst źródłaMitchell, Leslie A., Christian E. Overgaard, Christina Ward, Susan S. Margulies i Michael Koval. "Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function". American Journal of Physiology-Lung Cellular and Molecular Physiology 301, nr 1 (lipiec 2011): L40—L49. http://dx.doi.org/10.1152/ajplung.00299.2010.
Pełny tekst źródłaIshii, Mitsutoshi, Tomoshi Tsuchiya, Ryoichiro Doi, Yoichi Morofuji, Takashi Fujimoto, Hideki Muto, Takashi Suematsu i in. "Increased In Vitro Intercellular Barrier Function of Lung Epithelial Cells Using Adipose-Derived Mesenchymal Stem/Stromal Cells". Pharmaceutics 13, nr 8 (16.08.2021): 1264. http://dx.doi.org/10.3390/pharmaceutics13081264.
Pełny tekst źródłaRozprawy doktorskie na temat "Lung epithelial barrier function"
Zhai, Ruoyang. "Effects of sevoflurane in the treatment of Acute Respiratory Distress Syndrome : a translational approach". Electronic Thesis or Diss., Université Clermont Auvergne (2021-...), 2023. http://www.theses.fr/2023UCFA0077.
Pełny tekst źródłaAcute respiratory distress syndrome (ARDS) is a major cause of respiratory failurewith a high mortality rate. It is characterized by diffuse alveolar damage, alveolar edema, and hypoxemic respiratory loss which cause heavy healthcare costs. Currently, available treatments for ARDS remain primarily supportive, and no pharmacological approach is successfully translated into clinical application. There are two major processes during the physiopathological development of ARDS that lead to the formation of lung edema:alveolar barrier dysfunction and the impairment of alveolar fluid clearance following alveolar epithelial injury and inflammation. The receptor for advanced glycation end products (RAGE) was indicated to be involved during those processes, with the high potential of its soluble form as a biomarker for ARDS diagnostic and prognostic. Volatile halogenated agents, such as sevoflurane or isoflurane, are increasingly used in intensive care units as sedative agents with their ideal intrinsic characteristics as a sedative. Furthermore, numerous pre-clinical and clinical studies indicate its lung protective effects for ARDS patients.However, its mechanisms of such beneficial effects remain to be clarified.The main objectives of this thesis work are multiple, through experimental andtranslational in vivo and in vitro models of ARDS, to1) Asses the beneficial lung protective effects of sevoflurane in ARDS, including its effects on ARDS physiological features, lung fluid clearance, and alveolar permeability.2) Investigate the precise mechanism of observed effects of sevoflurane, including mechanistic studies and involved proteins' function and expression.3) Explore the role of RAGE in lung epithelial injury and repair and its eventualmediation role of the beneficial effects of sevoflurane.During this thesis work, we advanced from many angles: First, our work found in ourA549 cells wound healing model, the important role of RAGE in the lung injury repairprocess, as its ligand, HMGB1, and AGEs promoted RAGE-dependent wound healing oflung alveolar epithelial cells, which is possible through enhanced cell migration and proliferation.Secondly, our work in murine in vitro and in vivo ARDS models, animprovement of experimental features, with decreased indices of permeability and preserved epithelial structures in cells and mice, by at least in a part, increasing expression of ZO-1 and the inhibition of RhoA activity and pMLC as well as actin cytoskeleton rearrangement following lung epithelial injury. Additionally, RAGE may play a mediating role in the effects of sevoflurane on acute lung injury. Furthermore, our work in porcine in vivo ARDS models confirmed the lung protective effects of sevoflurane on ARDS features, with improved oxygenation, restored alveolar permeability, and improved AFC. Our study suggests theprotective effect of sevoflurane on AFC may be explained by the restoration of impaired lung expression of epithelial channels AQP-5, Na, K, ATPase, and ENaC during ARDS.Taken together, this thesis work explained more precisely the protective effects ofhalogenated agents and the new revelation of its potential mechanism, and hence supports the high interest in the use of inhaled sedation in intensive care for ARDS patients. This work may give some new insights for research on the effects of sevoflurane on ARDS and its resolution.Keywords: Acute respiratory distress syndrome; Sevoflurane; Lung epithelial barrierfunction; Lung wound repair; Alveolar fluid clearance; Epithelial channels: Junction proteins;Intracellular pathways; Receptor for advanced glycation end-products
Bueti, Deanna. "Immunomodulatory cytokines regulate intestinal epithelial barrier function /". Title page and abstract only, 2003. http://web4.library.adelaide.edu.au/theses/09SB/09sbb9289.pdf.
Pełny tekst źródłaKraft, Martin Rolf. "Giardia duodenalis - epithelial interaction and barrier function". Doctoral thesis, Humboldt-Universität zu Berlin, 2020. http://dx.doi.org/10.18452/21045.
Pełny tekst źródłaThe protozoan parasite Giardia duodenalis is the etiological agent for the intestinal diarrheal disease giardiasis. Infections are acquired via the fecal-oral route, mostly via uptake of cysts from contaminated drinking water. The colonization of the hosts’ duodenum and upper jejunum and the attachment of Giardia trophozoites onto the epithelium is the cause of a variety of gastrointestinal complaints but the exact pathomechanisms are unknown. Furthermore, the outcome of Giardia infections varies greatly between individuals, ranging from self-limiting to chronic, and asymptomatic to severe enteritis. One proposed mechanism for the pathogenesis is the breakdown of intestinal barrier function, e.g. by tight junction impairment or induction of cell death. In this work, effects of G. duodenalis on in vitro models of the human small intestinal epithelium were investigated by studying mainly barrier-related properties and changes of widely used Caco-2 cells as well as newly established human small intestinal organoid-derived monolayers (ODMs). It could be shown that several isolates of G. duodenalis, some described as highly virulent, fail to induce barrier dysfunction or any other investigated pathological effect on two Caco-2 cell lines under various infection and culturing conditions. On the other side, by developing a new organoid-based model system and the use of luminal mock medium TYI-S-33, considerable epithelial disruption (including loss of cells), cell death (apoptosis and non-apoptotic), tight junction impairment (degradation and dislocation of claudins and ZO-1), and microvilli depletion reproducibly induced by G. duodenalis trophozoites between one and two days after infection could be observed. Moreover, emergence of ClCa-1 positive cells with ongoing parasite infections suggest epithelial differentiation or metaplasia towards goblet cells, which is furthermore not associated to tissue damage.
Baker, Sarah Elizabeth. "Epithelial Sodium Channel Polymorphism Influences Lung Function". Diss., The University of Arizona, 2013. http://hdl.handle.net/10150/306770.
Pełny tekst źródłaBeltinger, Johannes Hermann. "Studies on colonic epithelial ion transport and barrier function". Thesis, University of Nottingham, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.311747.
Pełny tekst źródłaWillemsen, Linette Eustachia Maria. "Intestinal barrier function: regulation of epithelial permeability and mucin expression". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2004. http://dare.uva.nl/document/74526.
Pełny tekst źródłaGlymenaki, Maria. "The role of gut flora in epithelial barrier function and immunity". Thesis, University of Manchester, 2016. https://www.research.manchester.ac.uk/portal/en/theses/the-role-of-gut-flora-in-epithelial-barrier-function-and-immunity(6cb0ca1e-06ff-4cd4-a0a1-76ace6af2a55).html.
Pełny tekst źródłaRoux, Jérémie. "Function of the epithelial sodium channel ENaC in acute lung injury". Nice, 2005. http://www.theses.fr/2005NICE4010.
Pełny tekst źródłaThe objective of this thesis is to investigate the role of abnormalities in alveolar epithelial ion channel function in the pathogenesis of acute lung injury. Clinical studies have demonstrated that impaired alveolar fluid clearance associated with the release of inflammatory mediators within the distal airspace of the lung is a characteristic feature of acute lung injury. Therefore, we examined the potential effect of these mediators on ion transport across the alveolar epithelium. In the first study, we demonstrated that increased transforming growth factor -b1 (TGF-b1) activity in distal airspaces during acute lung injury promoted pulmonary edema by reducing alveolar epithelial sodium and fluid transport. In the second study we showed that in alveolar epithelial cells, interleukin -1b (IL-1b) activated TGF-b1 via an integrin avb6-dependent mechanism. Finally in the last study, we demonstrated that IL-1b could also directly and independently reduce the alveolar epithelial sodium and fluid transport. The reduction in fluid transport was shown to be attributable in large part to a decrease in apical membrane expression of the epithelial sodium channel (ENaC) in lung epithelial cells. The decreased cell surface expression of ENaC was mediated through a MAP kinase-dependent inhibition of ENaC promoter activity. In summary, the studies presented here demonstrate that IL-1b and TGF-b1 down-regulate ENaC biosynthesis and indicate a critical role for these mediators in the impaired fluid clearance of patients with acute lung injury
Le, Nga Thi Thanh. "Regulation of Intestinal Epithelial Barrier and Immune Function by Activated T Cells". Case Western Reserve University School of Graduate Studies / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1599833768774075.
Pełny tekst źródłaHU, Li-Li. "STAT3 in intestinal epithelial cells regulates barrier function and anti-bacterial response". Diss., [La Jolla] : University of California, San Diego, 2009. http://wwwlib.umi.com/cr/ucsd/fullcit?p1465075.
Pełny tekst źródłaTitle from first page of PDF file (viewed July 22, 2009). Available via ProQuest Digital Dissertations. Includes bibliographical references (p. 57-63).
Książki na temat "Lung epithelial barrier function"
E, Patterson Carolyn, red. Perspectives on lung endothelial barrier function. Amsterdam: Elsevier, 2005.
Znajdź pełny tekst źródłaPerspectives on Lung Endothelial Barrier Function. Elsevier, 2005. http://dx.doi.org/10.1016/s1569-2558(05)x3500-7.
Pełny tekst źródłaPatterson, C. E., i Edward Bittar. Perspectives on Lung Endothelial Barrier Function. Elsevier Science & Technology Books, 2004.
Znajdź pełny tekst źródłaPatterson, C. E. Perspectives on Lung Endothelial Barrier Function, Volume 35 (Advances in Molecular and Cell Biology). Elsevier Science, 2005.
Znajdź pełny tekst źródła(Editor), Jorg-Dieter Schulzke, Michael Fromm (Editor), Ernst-Otto Riecken (Editor) i Henry J. Binder (Editor), red. Epithelial Transport and Barrier Function: Pathomechanisms in Gastrointestinal Disorders (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2001.
Znajdź pełny tekst źródłaSchulzke, Jorg-Dieter. Epithelial Transport and Barrier Function: Pathomechanisms in Gastrointestinal Disorders (Annals of the New York Academy of Sciences, V. 915). New York Academy of Sciences, 2000.
Znajdź pełny tekst źródłaElger, Marlies, i Wilhelm Kriz. The renal glomerulus. Redaktor Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0043.
Pełny tekst źródłaSnell, Jamey, i Thomas J. Mancuso. Cystic Fibrosis. Redaktorzy Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi i Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0023.
Pełny tekst źródłaHarrois, Anatole, i Jacques Duranteau. Pathophysiology of severe capillary leak. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0164.
Pełny tekst źródłaPatterson, Caroline, i Meg Coleman. Revision Notes for the Respiratory Medicine Specialty Certificate Examination. Oxford University Press, 2012. http://dx.doi.org/10.1093/oso/9780199693481.001.0001.
Pełny tekst źródłaCzęści książek na temat "Lung epithelial barrier function"
Smith, Gideon P. "Normal Immune Function and Barrier: Epithelial Barrier". W Encyclopedia of Medical Immunology, 807–9. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-0-387-84828-0_267.
Pełny tekst źródłaMatthay, M. A., T. Nuckton i B. Daniel. "Alveolar Epithelial Barrier: Acute Lung Injury". W Yearbook of Intensive Care and Emergency Medicine, 189–205. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-13455-9_17.
Pełny tekst źródłaStrengert, Monika, i Ulla G. Knaus. "Analysis of Epithelial Barrier Integrity in Polarized Lung Epithelial Cells". W Methods in Molecular Biology, 195–206. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-191-8_13.
Pełny tekst źródłaRios-Arce, Naiomy Deliz, Fraser L. Collins, Jonathan D. Schepper, Michael D. Steury, Sandi Raehtz, Heather Mallin, Danny T. Schoenherr, Narayanan Parameswaran i Laura R. McCabe. "Epithelial Barrier Function in Gut-Bone Signaling". W Advances in Experimental Medicine and Biology, 151–83. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66653-2_8.
Pełny tekst źródłaMadara, James L., Shirin Nash, Ronda Moore, Michael Shapiro, Susan Carlson i Charlene Delp. "Barrier Function of Intestinal Epithelial Tight Junctions (TJ)". W Inflammatory Bowel Diseases 1990, 27–33. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-1980-8_4.
Pełny tekst źródłaAli, Shariq, i Erik Rytting. "Influences of Nanomaterials on the Barrier Function of Epithelial Cells". W Advances in Experimental Medicine and Biology, 45–54. Dordrecht: Springer Netherlands, 2014. http://dx.doi.org/10.1007/978-94-017-8739-0_3.
Pełny tekst źródłaKalifa, Lidza, i Michael A. O’Reilly. "The Impact of DNA Damage on Epithelial Cell Maintenance of the Lung". W Mitochondrial Function in Lung Health and Disease, 141–59. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0829-5_7.
Pełny tekst źródłaMatthay, M. A., G. Nitenberg i C. Jayr. "The Critical Role of the Alveolar Epithelial Barrier in Acute Lung Injury". W Yearbook of Intensive Care and Emergency Medicine, 28–43. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79154-3_3.
Pełny tekst źródłaPaugh, Jerry R., Alan Sasai i Abhay Joshi. "Preservative Effect on Epithelial Barrier Function Measured with a Novel Technique". W Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2, 731–35. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5359-5_103.
Pełny tekst źródłaStefanski, Adrianne L., Dorota S. Raclawska i Christopher M. Evans. "Modulation of Lung Epithelial Cell Function Using Conditional and Inducible Transgenic Approaches". W Methods in Molecular Biology, 169–201. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8570-8_14.
Pełny tekst źródłaStreszczenia konferencji na temat "Lung epithelial barrier function"
Muizer, Kirsten, Maaike De Vries, Wim Timens, Maarten Van Den Berge, Alen Faiz, Tillie-Louise Hackett, Corry-Anke Brandsma i Irene H. Heijink. "The effect of age on lung epithelial barrier function". W ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.oa2124.
Pełny tekst źródłaChen, Q., M. De Vries, M. Boezen i I. Heijink. "The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells". W ERS Lung Science Conference 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/23120541.lsc-2020.59.
Pełny tekst źródłaLaFemina, Michael J., Trevor Bentley, Katherine Sutherland, Deepti Rokkam, Lennell Allen, Leland G. Dobbs i James Frank. "A Role For Lung-Specific Tight Junction Protein Claudin-18 In Alveolar Epithelial Barrier Function". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6740.
Pełny tekst źródłaBoland, Helena, Endres Adrian, Hans Schwarzbach, Anke Burger-Kentischer, Danny Jonigk, Peter Braubach, Gernot Rohde i Carla Bellinghausen. "Protective effect of interferon type I on barrier function of human airway epithelium during rhinovirus infections in vitro". W ERS Lung Science Conference 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/23120541.lsc-2022.92.
Pełny tekst źródłaBoland, H., A. Endres, A. Burger-Kentischer, D. Jonigk, P. Braubach, G. Rohde i C. Bellinghausen. "Protective effect of interferon type I on barrier function of the human airway epithelium during rhinovirus infections in vitro". W ERS Lung Science Conference 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.lsc-2023.41.
Pełny tekst źródłaLaFemina, Michael J., Deepti Rokkam, Trevor M. Bentley, Michael A. Matthay i James A. Frank. "Bronchoalveolar Lavage Fluid From Patients With Acute Lung Injury Alters Barrier Function In Primary Alveolar Epithelial Cell Monolayers". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5096.
Pełny tekst źródłaLarsson, M., K. Balogh Sivars, M. Forsgard, M. Parsson i J. Hornberg. "MEK/ERK Inhibitors Affect Epithelial Barrier Function in Cells with Ongoing Active Repair Processes Indicating a Potential Hazard in Patients with Healing Lung". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5248.
Pełny tekst źródłaXiao, Cathy, Sarah A. Field, Joel Haywood, Victoria Broughton-Head, Nicole Bedke, Catherine Cremin, Stephen T. Holgate, Sarah M. Puddicombe, Phillip Monk i Donna E. Davies. "Defective Epithelial Barrier Function In Asthma". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a6367.
Pełny tekst źródłaSidhaye, Venkataramana, Eric Chau, Patrick Breysse i Landon S. King. "Particulate Matter Alters Airway Epithelial Barrier Function". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6392.
Pełny tekst źródłaGreaney, A. M., M. S. B. Raredon, T. Adams, R. Langer, N. Kaminski i L. E. Niklason. "Building Epithelial Barrier in Whole-lung Tissue Engineering". W American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6159.
Pełny tekst źródłaRaporty organizacyjne na temat "Lung epithelial barrier function"
Michael Anderson, Michael Anderson. Trans-epithelial Electrical Resistance (TEER) device to study the circadian rhythms of intestinal barrier function. Experiment, maj 2023. http://dx.doi.org/10.18258/51202.
Pełny tekst źródła